Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium

Clinical trial NCT03678454 · COMPLETED

Trial details

NCT number: NCT03678454
Sponsor: Incyte Biosciences Benelux
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Myeloid Leukemia CML Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Ph+ ALL

Start date: 2017-02-03
Primary completion: 2022-03-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.